The circadian rhythm is the body’s roughly 24-hour timing system for sleep, alertness, hormones, and other functions. In a small winter-depression study, morning light shifted the evening onset of melatonin earlier. Melatonin is a hormone that rises as the body prepares for night, so this change indicates that the internal clock moved earlier.

That measured clock shift does not establish the right schedule for everyone. In a 39-person seasonal trial, 22 of the 30 participants whose rhythms were measured had delayed circadian timing. Yet circadian phase did not predict depression severity or whether morning or evening

One randomized trial included 39 adults with seasonal affective disorder. After one week of 2,500-lux light for one hour, depression scores fell by at least half in 12 of 18 people assigned to morning light and 15 of 21 assigned to evening light. Both schedules produced a substantial response in this small, short trial.

A separate double-blind crossover study included only eight adults with winter depression and five controls. It found that morning light reduced depressive symptoms more than evening light. Together, these trials support a seasonal-mood benefit, but they are too small and brief

A 2024 meta-analysis combined 15 randomized trials involving 1,348 adults with major depressive disorder. Non-invasive neurostimulation improved reported sleep quality, sleep efficiency, and depressive symptoms compared with sham treatment or no stimulation. However, the analysis pooled bright light with treatments such as repetitive transcranial magnetic stimulation and transcranial direct-current stimulation. It therefore does not isolate the effect of bright light.

Direct bright-light trials were less encouraging. In a portable-device study with only 18 people in the final analysis, sleep improved within the active-light group, but active treatment did not outperform placebo for sleep quality, depression, or anxiety. In a

The studies reviewed here do not adequately report eye strain, retinal outcomes, photosensitivity, or longer-term eye safety. They also do not establish the risk of hypomania or mania in adults with bipolar disorder. The oncology trial excluded people with severe psychiatric disorders, while the other small trials do not provide enough condition-specific safety information to fill these gaps.

The National Institute of Mental Health link for seasonal affective disorder currently returns a page-not-found notice, so it provides no usable practical guidance. Based on the studies reviewed here, safety cannot be assumed for people with bipolar disorder, significant eye disease, migraine

The circadian rhythm is the body’s roughly 24-hour timing system for sleep, alertness, hormones, and other functions. In a small winter-depression study, morning light shifted the evening onset of melatonin earlier. Melatonin is a hormone that rises as the body prepares for night, so this change indicates that the internal clock moved earlier.

That measured clock shift does not establish the right schedule for everyone. In a 39-person seasonal trial, 22 of the 30 participants whose rhythms were measured had delayed circadian timing. Yet circadian phase did not predict depression severity or whether morning or evening

One randomized trial included 39 adults with seasonal affective disorder. After one week of 2,500-lux light for one hour, depression scores fell by at least half in 12 of 18 people assigned to morning light and 15 of 21 assigned to evening light. Both schedules produced a substantial response in this small, short trial.

A separate double-blind crossover study included only eight adults with winter depression and five controls. It found that morning light reduced depressive symptoms more than evening light. Together, these trials support a seasonal-mood benefit, but they are too small and brief

A 2024 meta-analysis combined 15 randomized trials involving 1,348 adults with major depressive disorder. Non-invasive neurostimulation improved reported sleep quality, sleep efficiency, and depressive symptoms compared with sham treatment or no stimulation. However, the analysis pooled bright light with treatments such as repetitive transcranial magnetic stimulation and transcranial direct-current stimulation. It therefore does not isolate the effect of bright light.

Direct bright-light trials were less encouraging. In a portable-device study with only 18 people in the final analysis, sleep improved within the active-light group, but active treatment did not outperform placebo for sleep quality, depression, or anxiety. In a

The studies reviewed here do not adequately report eye strain, retinal outcomes, photosensitivity, or longer-term eye safety. They also do not establish the risk of hypomania or mania in adults with bipolar disorder. The oncology trial excluded people with severe psychiatric disorders, while the other small trials do not provide enough condition-specific safety information to fill these gaps.

The National Institute of Mental Health link for seasonal affective disorder currently returns a page-not-found notice, so it provides no usable practical guidance. Based on the studies reviewed here, safety cannot be assumed for people with bipolar disorder, significant eye disease, migraine